Search
Aytu Biopharma Inc
AYTUAdd to Watchlist
2.160USD
+0.010+0.47%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
23.18MMarket Cap
LossP/E TTM
Aytu Biopharma Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
66.38M
-18.05%
EPS(YoY)
-2.16
24.51%
Analyst Rating
BUY
2026-07-01
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Aytu Biopharma Inc?
According to Aytu Biopharma Inc's FY2025 earnings report, its total revenue reached 66.38M, with a year-on-year change of -18.05.
What are the current assets of Aytu Biopharma Inc?
According to Aytu Biopharma Inc's FY2025 earnings report, its current assets were 79.18M, with a year-on-year change of 27.93.
What are the total assets of Aytu Biopharma Inc?
According to Aytu Biopharma Inc's FY2025 earnings report, its total assets of Aytu Biopharma Inc were 124.18M, with a year-on-year change of 5.15.
What are the total liabilities of Aytu Biopharma Inc?
According to Aytu Biopharma Inc's FY2025 earnings report, its total liabilities of Aytu Biopharma Inc were 105.21M, with a year-on-year change of 16.41.
What is the total equity of Aytu Biopharma Inc?
According to Aytu Biopharma Inc's FY2025 earnings report, its total equity of Aytu Biopharma Inc was 18.97M, with a year-on-year change of -31.57.
What is the net investment of Aytu Biopharma Inc?
According to Aytu Biopharma Inc's FY2025 earnings report, its net investment of Aytu Biopharma Inc was -2.56M, with a year-on-year change of -678.12.
What is the net financing of Aytu Biopharma Inc?
According to Aytu Biopharma Inc's FY2025 earnings report, its net financing of Aytu Biopharma Inc was 15.44M, with a year-on-year change of 1323.69.
What is the Earnings Per Share (EPS) of Aytu Biopharma Inc?
According to Aytu Biopharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.16, with a year-on-year change of 24.51.
What is the net margin of Aytu Biopharma Inc?
According to Aytu Biopharma Inc's FY2025 earnings report, its net profit margin was -21.36, with a year-on-year change of -9.22.
What is the gross margin of Aytu Biopharma Inc?
According to Aytu Biopharma Inc's FY2025 earnings report, its gross margin was 63.49, with a year-on-year change of 4.17.
What is the debt-to-asset ratio of Aytu Biopharma Inc?
According to Aytu Biopharma Inc's FY2025 earnings report, its debt-to-asset ratio was 17.57, with a year-on-year change of 37.13.
What is the Return on Equity (ROE) of Aytu Biopharma Inc?
According to Aytu Biopharma Inc's FY2025 earnings report, its Return on Equity (ROE) was -60.76, with a year-on-year change of -28.61.
What is the Return on Assets (ROA) of Aytu Biopharma Inc?
According to Aytu Biopharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -11.71, with a year-on-year change of 5.95.
What is the operating profit of Aytu Biopharma Inc?
According to Aytu Biopharma Inc's FY2025 earnings report, its operating profit was 2.54M, with a year-on-year change of 187.82.